H.R. 5316 · House bill · 119th Congress
Drug Shortage Compounding Patient Access Act of 2025 Introduced Sep 11, 2025 In committee Sep 11, 2025 Energy and Commerce Passed the House (not yet) Passed the Senate (not yet) Law (not yet) What it would change (3) About this text
3 sections of the Code · 35 changes asked for
Text: introduced in House Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Sep 11, 2025 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
This bill would let a pharmacist or physician compound limited quantities of a drug without a patient-specific prescription, for a prescriber's urgent use in a hospital or clinical setting. The drug must have been on the shortage list within the past 60 days, and the prescriber must certify that an outsourcing-facility version could not be obtained. Labeling, record-linking and 15-day adverse-event reporting rules would also apply. It would also require manufacturers of covered drugs to notify the Secretary of a surge in demand as soon as practicable, extend the covered drugs to include active pharmaceutical ingredients, and revise how a shortage is defined.
Summed up from the notes on 2 of the 3 sections the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
21 U.S.C. Chapter 9 · Federal Food, Drug, and Cosmetic Act 3 sections § 353a Pharmacy compounding 5 of 6 shown § 353b Outsourcing facilities 6 of 7 shown § 356c Discontinuance or interruption in the production of life-saving drugs 12 of 13 shown